The area of both the lumen and stent was measured every 1 mm and the percent neointimal area (%NIA) was calculated as the lumen/stent ×100. To quantify the prevalence of struts with PLIA, the percentage of stent struts with PLIA (%PLIA struts) was calculated as the number of struts with PLIA divided by the number of visible struts ×100.
Definition of PLIA
PLIA was defined as a region around stent struts with a homogeneous, lower intensity appearance than the surrounding tissue on OCT images without significant signal attenuation behind the area ( Figure 1A) . We judged the existence of PLIA only when we obtained clear stent strut images, and by the agreement of 2 independent experienced investigators blinded to the results of histology.
Histology
At 28 days, all pigs were killed humanely. The stented coronary arteries were dissected and serial cross-sections were obtained at 0.6-mm intervals. These sections were surfacestained with hematoxylin -eosin (HE). A subset of sections was stained with and Alcian blue. OCT images and HEstained cross-sections were matched within ±0.2 mm by the distance from the proximal end of the stent strut, as previously described. 2 Each histological specimen was oriented to TERAMOTO T et al.
the OCT image by the morphology of the stented lumen.
Statistical Analysis
Statistical analyses were performed with JMP 7 (SAS institute Inc, Cary, NC, USA). Unpaired t-test was used for the analysis of continuous variables. A P-value <0.05 was considered statistically significant.
Results
Of 36 stents, PLIA was observed in 16 (SES 9, PES 4, BMS 3). The incidence of PLIA was significantly higher in DES than in BMS (65% (13/20) vs 19% (3/16), P<0.001). Among stents with PLIA, no significant difference was observed in %PLIA struts between DES and BMS (44.0±23.7% vs 40.0± 21.8%, P=0.89). Overall, stents with PLIA showed significantly greater %NIA than stents without PLIA (47.8±18.9% vs 34.6±18.7%, P=0.04). This difference still existed in each stent group (BMS: 63.0±14.5% vs 35.0±16.5%, P<0.01; DES: 45.5±18.3% vs 27.6±18.9%, P=0.05).
Among the DES, SES showed a numerically higher incidence of PLIA than PES (73% (8/11) vs 56% (5/9), P=0.15). The %NIA was numerically but nonsignificantly greater with SES than with PES (40.7±22.1% vs 31.4±18.6%, P=0.30). Similarly, among stents with PLIA, a numerically greater %PLIA struts was observed with SES than with PES (43.2± 26.3% vs 31.3±10.9%, P=0.26).
Histological analysis showed a neointima typically consisting of an innermost neointimal layer with a concentric orientation of smooth muscle cells ( Figure 1B) . The regions corresponding with PLIA were distinguished as hypocellular regions on HE staining, suggesting the presence of fibrinoid (pink) or proteoglycans (less intensely stained with HE) ( Figure 1C ). Additionally, a polymorphic response associated with wound healing (eg, a small number of macrophages and lymphocytes) was observed surrounding these hypocellular regions ( Figure 1D ). Alcian blue staining revealed the presence of proteoglycans throughout the intima, but not around stent struts (Figure 2) .
Discussion
To the best of our knowledge, this is the first report of the 
Peri-Strut Low Intensity Area on OCT
histological changes corresponding with PLIA seen on OCT images. After stent deployment, it is generally considered that neointimal formation involves the replacement of fibrin by extracellular matrix. Judging from the pathological findings of the present study, PLIA might represent the existence of fibrinoid. Neither eosinophilic cell infiltration nor proteoglycans was observed in direct association with the struts in these regions.
In a recent human pathological study, Beusekom et al clearly showed the presence of acellular areas after DES implantation, but not with BMS, 3 which appears to support our finding that PLIA was observed more frequently with DES than BMS. In a study assessing the relationship between sirolimus dose and pathological findings, fibrinoid tissue surrounding SES struts was observed in a sirolimus-dosedependent manner. 4 Considered together, drug eluted from DES might contribute to the process of PLIA formation. The presence of PLIA might reflect a difference between DES and BMS for arterial healing. 5 According to previous studies, extracellular matrix remodeling plays an essential role in neointimal formation and excessive matrix formation is a determinant of failure of radiation therapy. 6,7 Our findings are in accordance with those reports, showing greater neointimal proliferation in stents with PLIA than in stents without PLIA, for both DES and BMS. In contrast to a human study, 8 SES showed numerically greater %NIA than PES in this porcine model. Interestingly, SES also showed a numerically higher incidence of PLIA than PES, with a greater prevalence of struts with PLIA. These findings might represent different healing processes with SES and PES, 9 which may be associated with different neointimal proliferation during follow-up. Further evaluation might be needed for the better understanding of the possible role of PLIA in the process of arterial healing after stenting.
Study Limitations
First, porcine vascular reactivity to intravascular intervention may differ from that of humans. Second, despite our endeavors for precision, the judgment of the existence of PLIA might include some intuition. Finally, technical limitations include the difficulty in exactly matching the histologic cross-sections with the OCT images.
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